CD47 and colorectal cancer: This is illustrated in Figure 3D–F, which shows that diHEP-DPA blocked the CD47/SIRPα axis by directly or indirectly reducing the expression of these proteins, and thus enhanced the phagocytosis of live, intact colorectal cancer cells (HT29 and HCT116) by TAMs.